DK453882A - Fremgangsmaade til fremstilling af triazinderivater - Google Patents
Fremgangsmaade til fremstilling af triazinderivater Download PDFInfo
- Publication number
- DK453882A DK453882A DK453882A DK453882A DK453882A DK 453882 A DK453882 A DK 453882A DK 453882 A DK453882 A DK 453882A DK 453882 A DK453882 A DK 453882A DK 453882 A DK453882 A DK 453882A
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- preparation
- triazine derivatives
- triazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8131900 | 1981-10-22 | ||
| GB8224151 | 1982-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK453882A true DK453882A (da) | 1983-04-23 |
Family
ID=26281042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK453882A DK453882A (da) | 1981-10-22 | 1982-10-13 | Fremgangsmaade til fremstilling af triazinderivater |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4616014A (no) |
| EP (1) | EP0077983B1 (no) |
| JP (1) | JPS5899468A (no) |
| AU (1) | AU8926982A (no) |
| DE (1) | DE3276164D1 (no) |
| DK (1) | DK453882A (no) |
| ES (3) | ES516724A0 (no) |
| FI (1) | FI823544L (no) |
| GR (1) | GR76714B (no) |
| NO (1) | NO823506L (no) |
| OA (1) | OA07236A (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1199027A (en) * | 1981-11-12 | 1986-01-07 | Stuart D. Mills | Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone |
| US4581356A (en) * | 1983-03-22 | 1986-04-08 | Fujisawa Pharmaceutical Co., Ltd. | Triazine derivatives, and pharmaceutical compositions comprising the same |
| JPS59196874A (ja) * | 1983-04-22 | 1984-11-08 | Fujisawa Pharmaceut Co Ltd | トリアジン誘導体 |
| GB8328757D0 (en) * | 1983-10-27 | 1983-11-30 | Wellcome Found | Chemical compounds |
| GB8612796D0 (en) * | 1986-05-27 | 1986-07-02 | Fbc Ltd | Fungicides |
| US4970210A (en) * | 1987-07-17 | 1990-11-13 | Abbott Laboratories | Triazinone lipoxygenase compounds |
| CN1038249C (zh) * | 1991-08-28 | 1998-05-06 | 罗姆和哈斯公司 | 含有二氢哒嗪酮及其相关化合物的杀菌组合物 |
| IT1318392B1 (it) | 2000-03-15 | 2003-08-25 | Getters Spa | Composizione getter di idrogeno. |
| EP1328275B1 (en) * | 2000-10-27 | 2008-05-07 | Dow AgroSciences LLC | Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides |
| BR0115262A (pt) * | 2000-11-09 | 2003-08-12 | Mitsui Chemicals Inc | Derivados de amina opticamente ativos e processo de preparação destes |
| US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
| WO2004005262A2 (en) * | 2002-07-02 | 2004-01-15 | Schering Corporation | New neuropeptide y y5 receptor antagonists |
| US7323455B2 (en) | 2004-03-24 | 2008-01-29 | Wyeth | 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators |
| EP2233470B1 (en) * | 2005-07-04 | 2011-12-07 | High Point Pharmaceuticals, LLC | Histamine H3 receptor antagonists |
| RU2442775C2 (ru) * | 2005-07-04 | 2012-02-20 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
| JP2009537596A (ja) * | 2006-05-23 | 2009-10-29 | ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー | ６−（４−シクロプロピルピペリジン−１−イル）−２’−メチル−［３，４’］−ビピリジン及びその医薬としての使用 |
| SG163547A1 (en) * | 2006-05-29 | 2010-08-30 | High Point Pharmaceuticals Llc | 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
| EP2014656A3 (en) * | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1604084A (en) * | 1977-05-17 | 1981-12-02 | Diamond Shamrock Corp | Pharmaceutical preparations containing 1,2,4-triazine derivatives |
| US4157392A (en) * | 1977-05-17 | 1979-06-05 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
| DE3172252D1 (en) * | 1980-11-14 | 1985-10-17 | Ici Plc | Heterocyclic compounds |
| US4495185A (en) * | 1981-11-12 | 1985-01-22 | Imperial Chemical Industries, Plc | 1,2,4-Triazin-3(2H) ones |
| US4581356A (en) * | 1983-03-22 | 1986-04-08 | Fujisawa Pharmaceutical Co., Ltd. | Triazine derivatives, and pharmaceutical compositions comprising the same |
-
1982
- 1982-10-08 US US06/433,513 patent/US4616014A/en not_active Expired - Fee Related
- 1982-10-11 GR GR69503A patent/GR76714B/el unknown
- 1982-10-11 AU AU89269/82A patent/AU8926982A/en not_active Abandoned
- 1982-10-13 DK DK453882A patent/DK453882A/da not_active Application Discontinuation
- 1982-10-15 EP EP82109529A patent/EP0077983B1/en not_active Expired
- 1982-10-15 DE DE8282109529T patent/DE3276164D1/de not_active Expired
- 1982-10-18 FI FI823544A patent/FI823544L/fi not_active Application Discontinuation
- 1982-10-21 ES ES516724A patent/ES516724A0/es active Granted
- 1982-10-21 NO NO823506A patent/NO823506L/no unknown
- 1982-10-22 OA OA57828A patent/OA07236A/xx unknown
- 1982-10-22 JP JP57186641A patent/JPS5899468A/ja active Pending
-
1983
- 1983-06-15 ES ES523300A patent/ES523300A0/es active Granted
- 1983-06-15 ES ES523299A patent/ES8601934A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES8401042A1 (es) | 1983-11-16 |
| US4616014A (en) | 1986-10-07 |
| OA07236A (fr) | 1984-04-30 |
| DE3276164D1 (en) | 1987-06-04 |
| EP0077983B1 (en) | 1987-04-29 |
| ES8500247A1 (es) | 1984-10-01 |
| ES523299A0 (es) | 1985-04-16 |
| ES523300A0 (es) | 1984-10-01 |
| EP0077983A1 (en) | 1983-05-04 |
| ES8601934A1 (es) | 1985-04-16 |
| FI823544A0 (fi) | 1982-10-18 |
| ES516724A0 (es) | 1983-11-16 |
| NO823506L (no) | 1983-04-25 |
| GR76714B (no) | 1984-08-29 |
| FI823544L (fi) | 1983-04-23 |
| AU8926982A (en) | 1983-04-28 |
| JPS5899468A (ja) | 1983-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK112582A (da) | Fremgangsmaade til fremstilling af triazolonderivater | |
| DK66582A (da) | Fremgangsmaade til fremstilling af carbostyrilderivater | |
| DK50482A (da) | Fremgangsmaade til fremstilling af quinazolinderivater | |
| DK534481A (da) | Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater | |
| DK99781A (da) | Fremgangsmaade til fremstilling af carboxtyrilderivater | |
| DK2281A (da) | Fremgangsmaade til fremstilling af tiazolinderivater | |
| DK316582A (da) | Fremgangsmaade til fremstilling af bicykliske pyrimidin-5-on-derivater | |
| DK300981A (da) | Fremgangsmaade til fremstilling af imidazolderivater | |
| DK65882A (da) | Fremgangsmaade til fremstilling af substituerede phosphonamider | |
| DK84082A (da) | Fremgangsmaade til fremstilling af pg12-derivater | |
| DK161581A (da) | Fremgangsmaade til fremstilling af imidazolderivater | |
| DK491582A (da) | Fremgangsmaade til fremstilling af morphinanderivater | |
| DK453882A (da) | Fremgangsmaade til fremstilling af triazinderivater | |
| DK352082A (da) | Fremgangsmaade til fremstilling af ergopeptinderivater | |
| DK100281A (da) | Fremgangsmaade til fremstilling af imidazolderivater | |
| DK241982A (da) | Fremgangsmaade til fremstilling af carboximidderivater | |
| DK160555C (da) | Fremgangsmaade til fremstilling af eburnamoninderivater | |
| DK116982A (da) | Fremgangsmaade til fremstilling af alkylendioxybenzenderivater | |
| DK564781A (da) | Fremgangsmaade til fremstilling af pyrazoloindazolderivater | |
| DK554581A (da) | Fremgangsmaade til fremstilling af alkylendioxybenzenderivater | |
| DK172181A (da) | Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater | |
| DK565281A (da) | Fremgangsmaade til fremstilling af quinolon-derivater | |
| DK85281A (da) | Fremgangsmaade til fremstilling af phenoxyderivater | |
| DK448981A (da) | Fremgangsmaade til fremstilling af 4-chinolinmethanderivater | |
| DK424781A (da) | Fremgangsmaade til fremstilling af quinolonderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |